All fields · Immunology and Allergy

JournalQ1· SCImago 2025

Signal Transduction and Targeted Therapy

ISSN 2059-3635

• Q1Quartile
• 17.00SJR
• 224h-index
• 9papers summarised

About this journal

Signal Transduction and Targeted Therapy is a Q1 journal by SCImago Journal Rank (2025 data), with an SJR of 17.00 and an h-index of 224. Most of its papers in the Pofolia pool fall under Immunology and Allergy. Pofolia holds AI summaries of 9 paper(s) from this journal; the most cited is “The blood–brain barrier: Structure, regulation and drug delivery” (1666 citations).

The quartile (Q1–Q4) is the journal's percentile position within its subject area by SCImago Journal Rank; Q1 is the top 25%. What is a Q1 journal?

Papers we summarise from this journal

• The blood–brain barrier: Structure, regulation and drug delivery2023 · 1666 citations
• Microglia in neurodegenerative diseases: mechanism and potential therapeutic targets2023 · 1436 citations
• Targeting integrin pathways: mechanisms and advances in therapy2023 · 1215 citations
• The mechanisms of sorafenib resistance in hepatocellular carcinoma: theoretical basis and therapeutic aspects2020 · 1143 citations
• Osteoarthritis: pathogenic signaling pathways and therapeutic targets2023 · 1090 citations
• Notch signaling pathway: architecture, disease, and therapeutics2022 · 1068 citations
• Major depressive disorder: hypothesis, mechanism, prevention and treatment2024 · 942 citations
• The sirtuin family in health and disease2022 · 802 citations
• TRP (transient receptor potential) ion channel family: structures, biological functions and therapeutic interventions for diseases2023 · 487 citations

Journals in the same field

See every journal in the field →